FUHS ULRICH MARTIN 4
4 · ALPINE IMMUNE SCIENCES, INC. · Filed May 10, 2024
Insider Transaction Report
Form 4
FUHS ULRICH MARTIN
Chief Accounting Officer
Transactions
- Exercise/Conversion
Stock Option (Right to buy)
2024-05-08−22,820→ 52,180 totalExercise: $12.07Exp: 2031-12-05→ Common Stock (22,820 underlying) - Exercise/Conversion
Common Stock
2024-05-08$12.07/sh+22,820$275,437→ 30,120 total
Footnotes (2)
- [F1]Includes 7,300 shares of common stock underlying a restricted stock unit grant made on March 14, 2024.
- [F2]1/4th of the shares subject to the option vested on November 30, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the reporting person continuing to be a service provider through each date.